Business
Insulet to Present at Nasdaq’s 45th Investor Conference
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand
About this update from Insulet Corporation
[{"type":"text","content":" ACTON, Mass.--(BUSINESS WIRE)--\nInsulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the virtual 45th Nasdaq Investor Conference on Friday, December 3, 2021 at 11:30 a.m. (Eastern Time).\n\nTo listen to the live webcast of the presentation, please visit investors.insulet.com/events. A replay of the webcast will also be available following the event.\n\nAbout Insulet Corporation:\n\nInsulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211124005071/en/\n\nInvestor Relations:\n\nDeborah R. Gordon\nVice President, Investor Relations\n(978) 600-7717\[email protected]\n\nMerrill Robichaud\nInvestor Relations Coordinator\n(978) 932-0444\[email protected]\n\nMedia:\n\nAngela Geryak Wiczek\nSenior Director, Corporate Communications\n(978) 932-0611\[email protected]\n\nSource: Insulet Corporation","length":4093,"tagName":"div"}]